ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HIND vs JAGX // DIVIDEND YIELD & FCF PAYOUT SAFETY

Vyome Holdings Inc. (NASDAQ) VS. Jaguar Health Inc. (NASDAQ) • 15-METRIC TALLY: HIND 3 — JAGX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HIND VS. JAGX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HIND JAGX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 68.40% 67.20% +1.20 HIND /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -0.50% -59.50 JAGX /net-margins <GO>
Revenue Growth (YoY) -65.00% -1.50% -63.50 JAGX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 HIND /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.9 40.2 +2.70 HIND /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.6M $12.6M -$6.1K JAGX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HIND REV JAGX REV HIND GROSS % JAGX GROSS % HIND FCF JAGX FCF
FY 2025 $319.7K $11.5M 68.4% 67.2% -$3.7M -$23.7M
FY 2024 $8.0M $11.7M 2.4% 83.3% -$614.1K -$29.4M
FY 2023 $8.7M $9.8M — — -$17.0M -$33.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HIND // BETA —
JAGX // BETA —